BALAKRISHNA R RAGOOR

Allopathic & Osteopathic Physicians|Family Medicine MONROEVILLE, PA NPI 1568436152

General Payments — all program years on this page

$16,693.53

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 667
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,462.65 across 39 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,372.6538
Education $90.001

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $341.198
Acerta Pharma LLC $227.005
Lilly USA, LLC $198.926
ABBVIE INC. $171.058
Grifols USA, LLC $151.371
Gilead Sciences, Inc. $138.152
Astellas Pharma US Inc $107.632
GlaxoSmithKline, LLC. $71.184
Novo Nordisk AS $42.522
PFIZER INC. $13.641

By program year

Program yearAmountRecords
2018 $4,121.65221
2019 $4,357.25207
2020 $1,210.8542
2021 $1,416.6238
2022 $1,885.6544
2023 $2,238.8676
2024 $1,462.6539

Records — PY2024 (39)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096603803 Novo Nordisk Inc $22.60 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096939583 Novo Nordisk Inc $19.92 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104357421 AstraZeneca Pharmaceuticals LP $20.76 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104524124 AstraZeneca Pharmaceuticals LP $17.68 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104615718 AstraZeneca Pharmaceuticals LP $21.46 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104676627 AstraZeneca Pharmaceuticals LP $125.10 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105230130 AstraZeneca Pharmaceuticals LP $42.00 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105350142 ABBVIE INC. $24.25 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105350147 ABBVIE INC. $10.31 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105350151 ABBVIE INC. $19.50 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105350155 ABBVIE INC. $13.70 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105350159 ABBVIE INC. $2.65 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105350163 ABBVIE INC. $20.21 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105350167 ABBVIE INC. $23.72 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105350171 ABBVIE INC. $56.71 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111681778 Amgen Inc. $20.17 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111681780 Amgen Inc. $115.00 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111681782 Amgen Inc. $116.25 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111681784 Amgen Inc. $11.55 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111681786 Amgen Inc. $20.01 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111681788 Amgen Inc. $15.73 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115971641 GlaxoSmithKline, LLC. $18.79 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116306335 GlaxoSmithKline, LLC. $15.85 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116471128 GlaxoSmithKline, LLC. $15.29 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116485345 GlaxoSmithKline, LLC. $21.25 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117359596 Amgen Inc. $21.51 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117359598 Amgen Inc. $20.97 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124721663 Grifols USA, LLC $151.37 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131809105 PFIZER INC. $13.64 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133739516 Gilead Sciences, Inc. $125.00 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133739518 Gilead Sciences, Inc. $13.15 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136004417 Lilly USA, LLC $23.36 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136004419 Lilly USA, LLC $101.88 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136060640 Lilly USA, LLC $14.11 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136060642 Lilly USA, LLC $21.85 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136061062 Lilly USA, LLC $17.25 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136061694 Lilly USA, LLC $20.47 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139265886 Astellas Pharma US Inc $17.63 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139344504 Astellas Pharma US Inc $90.00 03/07/2024 Education Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.